CURETTE, EAR

The contract solicitation SPE2DS-26-T-270U is issued by the Defense Logistics Agency under the Department of Defense for the procurement of two cases of CURETTE, EAR, each containing fifty units, with the NSN 6515-01-290-8955. The solicitation is a firm-fixed-price contract utilizing Alternate I of FAR 52.216-1 and incorporates a deviation (2026-00038) affecting multiple clauses, including representation requirements, equal opportunity, combating human trafficking, employment eligibility verification, sustainable products, and hazardous material handling. The procurement is governed by stringent packaging and marking standards, requiring compliance with MIL-STD-2073-1E for packaging and preservation and Medical Marking Standard No. 1 for labeling, which supersedes MIL-STD-129 for medical items except when handling radioactive materials above threshold levels. Hazardous materials must be labeled per OSHA’s Hazard Communication Standard and accompanied by complete Safety Data Sheets prior to award, with noncompliance leading to disqualification. The delivery is due within 20 days of award, to be shipped FOB destination to Fort Indiantown Gap, Pennsylvania, with the contractor bearing all transportation costs and risks until delivery at the specified location. All invoices must be submitted electronically via WAWF, and the contract includes extensive cybersecurity and information safeguarding requirements under DFARS clauses, including safeguarding covered defense information and cyber incident reporting, prohibitions on certain telecommunications equipment, and limitations on third-party data disclosure. Offerors must possess a current Unique Entity ID and CAGE code, and are required to submit self-representations regarding small business status and socioeconomic certifications if claiming such designations. Proposals must be submitted electronically through DIBBS by August 3, 2026, and must include technical documentation for both the primary and alternate parts in accordance with DLA Master Solicitation Revision 105 and Medical Marking Standard No. 1. The absence of pricing details in the CLIN table means the contract value remains undetermined at this stage, and no evaluation factors or award methodology are explicitly stated, though the nature of the acquisition suggests a potential lowest price technically acceptable approach. The contracting officer’s representative and payment office details are not included in the solicitation but will be specified in the resulting award document.